Indonesia Empty Capsules Market

Indonesia Empty Capsules Market Size, Share, Growth Analysis, By Type(Gelatin capsules (Hard Gelatin, Soft Gelatin), and Non Gelatin capsules (Hydroxypropyl Methylcellulose, Pullulan & Starch), By Origin(Vegetarian Origin, and Animal Origin), By Functionality(Immediate-release Capsules, Sustained-release Capsules, and Delayed-release Capsules), By Therapeutic Application(Antibiotic & Antibacterial Drugs, Dietary Supplements, Antacid & Antiflatulent, Anti-anemic Preparations), By End User(Pharmaceutical Industry, Nutraceutical Industry, Cosmetic Industry, and Research Laboratories), By Region - Industry Forecast 2024-2031

Report ID: SQMIC35I2335 | Region: Country | Published Date: July, 2024
Pages: 174 | Tables: 151 | Figures: 68

Indonesia Empty Capsules Market Competitive Landscape

The Indonesia Empty Capsules Market is highly competitive and fragmented, with numerous players operating in the market. Some of the key strategies adopted by players in the market include mergers and acquisitions, and new product launches. The market is also characterized by a high degree of innovation, with companies investing in R&D to develop new and advanced products.

Top Player’s Company Profiles

  • Qualicaps, Inc. (United States)
  • Snail Pharma Industry Co., Ltd. (China)
  • Natural Capsules Ltd. (India)
  • Shangdong Healsee Capsule Ltd. (China)
  • ACG (India)
  • Capsuline (United States)
  • Xinchang County No.6 Capsule Factory (China)
  • Mtntai (China)
  • Xinchang County Top Health Capsule Co. (China)

$3,500
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Indonesia Empty Capsules Market size was valued at USD 4.20 million in 2022 and is poised to grow from USD 4.47 billion in 2023 to USD 7.23 billion by 2031, growing at a CAGR of 6.3% during the forecast period (2024-2031).

The Indonesia Empty Capsules Market is highly competitive and fragmented, with numerous players operating in the market. Some of the key strategies adopted by players in the market include mergers and acquisitions, and new product launches. The market is also characterized by a high degree of innovation, with companies investing in R&D to develop new and advanced products. 'Lonza Group Ltd. (Switzerland)', 'Qualicaps, Inc. (United States)', 'Snail Pharma Industry Co., Ltd. (China)', 'Natural Capsules Ltd. (India)', 'Shangdong Healsee Capsule Ltd. (China)', 'ACG (India)', 'Capsuline (United States)', 'Xinchang County No.6 Capsule Factory (China)', 'Mtntai (China)', 'Xinchang County Top Health Capsule Co. (China)'

Presently, consumer awareness and demand for dietary supplements drive the empty capsules market in Indonesia. This trend is because of the fast-growing interest in dietary supplements and functional foods, further accelerated by the pandemic. The dietary supplements market in Indonesia stood at approximately 2.35 billion USD and is projected to grow at a CAGR of around 7%. Capsules bring versatility and convenience to the consumer due to their ease of ingestion and stability, thereby placing them as a preferred choice. As health-conscious choices evolve, the demand for empty capsules will continue to grow, supported by advancements in nutraceutical formulations and regulatory frameworks.

Increasing Demand for Vegetable-based Capsules: As more consumers are seeking vegan and vegetarian products, the demand for vegetable-based capsules made from materials such as hypromellose (HPMC) and pullulan is increasing. These capsules offer a plant-based alternative to gelatin capsules, which are made from animal by-products.

Our analysis indicates that in 2023 Indonesia’s empty capsule market represents approximately 2% of the total empty capsule market in the Asia-Pacific region. As Indonesia’s pharmaceutical industry continues to grow, driven by increasing healthcare demands and expanding production capacities, the empty capsule sector is also expected to experience significant expansion. The rising number of pharmaceutical manufacturing units and the growing adoption of capsules for drug delivery are likely to drive demand, contributing to a notable increase in Indonesia’s market share within the Asia-Pacific region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Feedback From Our Clients

Indonesia Empty Capsules Market

Report ID: SQMIC35I2335

$3,500
BUY NOW GET FREE SAMPLE